TY - JOUR
T1 - HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study
AU - Kucharska-Newton, Anna M.
AU - Rosamond, Wayne D.
AU - Schroeder, Jane C.
AU - McNeill, Ann Marie
AU - Coresh, Josef
AU - Folsom, Aaron R.
N1 - Funding Information:
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The authors thank the staff and participants of the ARIC study for their important contributions.
PY - 2008/9
Y1 - 2008/9
N2 - This study examined prospectively the association of baseline plasma HDL-cholesterol levels with incidence of lung cancer in 14,547 members of the Atherosclerosis Risk in Communities (ARIC) cohort. There were 259 cases of incident lung cancer identified during follow-up from 1987 through 2000. Results of this study indicated a relatively weak inverse association of HDL-cholesterol with lung cancer that was dependent on smoking status. The hazard ratio of lung cancer incidence in relation to low HDL-cholesterol, adjusted for race, gender, exercise, alcohol consumption, body mass index, triglycerides, age, and cigarette pack-years of smoking, was 1.45 (95% confidence interval 1.10, 1.92). This association was observed among former smokers (hazard ratio: 1.77, 95% confidence interval 1.05, 2.97), but not current smokers. The number of cases among never smokers in this study was too small (n = 13) for meaningful interpretation of effect estimates. Excluding cases occurring within 5 years of baseline did not appreciably change the point estimates, suggesting lack of reverse causality. The modest association of low plasma HDL-cholesterol with greater incident lung cancer observed in this study is in agreement with existing case-control studies.
AB - This study examined prospectively the association of baseline plasma HDL-cholesterol levels with incidence of lung cancer in 14,547 members of the Atherosclerosis Risk in Communities (ARIC) cohort. There were 259 cases of incident lung cancer identified during follow-up from 1987 through 2000. Results of this study indicated a relatively weak inverse association of HDL-cholesterol with lung cancer that was dependent on smoking status. The hazard ratio of lung cancer incidence in relation to low HDL-cholesterol, adjusted for race, gender, exercise, alcohol consumption, body mass index, triglycerides, age, and cigarette pack-years of smoking, was 1.45 (95% confidence interval 1.10, 1.92). This association was observed among former smokers (hazard ratio: 1.77, 95% confidence interval 1.05, 2.97), but not current smokers. The number of cases among never smokers in this study was too small (n = 13) for meaningful interpretation of effect estimates. Excluding cases occurring within 5 years of baseline did not appreciably change the point estimates, suggesting lack of reverse causality. The modest association of low plasma HDL-cholesterol with greater incident lung cancer observed in this study is in agreement with existing case-control studies.
KW - Cohort studies
KW - HDL-cholesterol
KW - Lipoproteins
KW - Lung neoplasms
UR - http://www.scopus.com/inward/record.url?scp=50849121989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=50849121989&partnerID=8YFLogxK
U2 - 10.1016/j.lungcan.2008.01.015
DO - 10.1016/j.lungcan.2008.01.015
M3 - Article
C2 - 18342390
AN - SCOPUS:50849121989
SN - 0169-5002
VL - 61
SP - 292
EP - 300
JO - Lung Cancer
JF - Lung Cancer
IS - 3
ER -